Preclinical safety evaluation of biopharmaceuticals a science-based approach to facilitating clinical trials
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Hoboken, N.J.
Wiley
c2008
|
| Schlagworte: | |
| Online-Zugang: | FRO01 UBG01 URL des Erstveröffentlichers |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043388951 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160222s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 9780470292549 |9 978-0-470-29254-9 | ||
| 020 | |a 0470292547 |9 0-470-29254-7 | ||
| 020 | |a 9780470292532 |9 978-0-470-29253-2 | ||
| 020 | |a 0470292539 |9 0-470-29253-9 | ||
| 020 | |a 1281732818 |9 1-281-73281-8 | ||
| 020 | |a 9781281732811 |9 978-1-281-73281-1 | ||
| 024 | 7 | |a 10.1002/9780470292549 |2 doi | |
| 035 | |a (ZDB-35-WIC)ocn264615469 | ||
| 035 | |a (OCoLC)264615469 | ||
| 035 | |a (DE-599)BVBBV043388951 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-861 | ||
| 082 | 0 | |a 615/.19 |2 22 | |
| 084 | |a VS 5360 |0 (DE-625)147688:253 |2 rvk | ||
| 245 | 1 | 0 | |a Preclinical safety evaluation of biopharmaceuticals |b a science-based approach to facilitating clinical trials |c edited by Joy A. Cavagnaro |
| 264 | 1 | |a Hoboken, N.J. |b Wiley |c c2008 | |
| 300 | |a 1 Online-Ressource (xxvi, 1033 p., [8] p. of plates) |c 25 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a "The goal is to provide a comprehensive reference book for the preclinicaldiscovery and development scientist whose responsibilities span target identification, lead candidate selection, pharmacokinetics, pharmacology, and toxicology, and for regulatory scientists whose responsibilities include the evaluation of novel therapies.".-From the Afterword by Anthony D. Dayan. Proper preclinical safety evaluation can improve the predictive value, lessen the time and cost of launching new biopharmaceuticals, and speed potentially lifesaving drugs to market. This guide covers topics ranging | ||
| 533 | |a Online-Ausgabe |n Mode of access: World Wide Web | ||
| 650 | 7 | |a Drugs / Testing |2 fast | |
| 650 | 7 | |a Pharmaceutical biotechnology / Safety measures |2 fast | |
| 650 | 4 | |a Clinical Trials as Topic / methods | |
| 650 | 4 | |a Biological Products | |
| 650 | 4 | |a Clinical Trials as Topic / legislation & jurisprudence | |
| 650 | 4 | |a Drug Evaluation, Preclinical / methods | |
| 650 | 7 | |a MEDICAL / Drug Guides |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Pharmacy |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Nursing / Pharmacology |2 bisacsh | |
| 650 | 4 | |a Biological products | |
| 650 | 4 | |a Clinical Trials as Topic | |
| 650 | 4 | |a Drug Evaluation, Preclinical | |
| 650 | 4 | |a Drugs | |
| 650 | 4 | |a Pharmaceutical biotechnology | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Pharmaceutical biotechnology / Safety measures | |
| 650 | 4 | |a Drugs / Testing | |
| 650 | 0 | 7 | |a Biologika |0 (DE-588)7689632-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Klinisches Experiment |0 (DE-588)4164223-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelüberwachung |0 (DE-588)4437717-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Chemie |0 (DE-588)4132158-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Bioverfahrenstechnik |0 (DE-588)4307166-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Chemie |0 (DE-588)4132158-3 |D s |
| 689 | 0 | 1 | |a Biologika |0 (DE-588)7689632-8 |D s |
| 689 | 0 | 2 | |a Bioverfahrenstechnik |0 (DE-588)4307166-1 |D s |
| 689 | 0 | 3 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
| 689 | 0 | 4 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
| 689 | 0 | 5 | |a Arzneimittelüberwachung |0 (DE-588)4437717-4 |D s |
| 689 | 0 | 6 | |a Klinisches Experiment |0 (DE-588)4164223-5 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Cavagnaro, Joy A. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Reproduktion von |t Preclinical safety evaluation of biopharmaceuticals |d c2008 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-470-10884-3 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-470-10884-0 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9780470292549 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-35-WIC | ||
| 940 | 1 | |q UBG_PDA_WIC | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028807535 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9780470292549 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9780470292549 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175961328975872 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043388951 |
| classification_rvk | VS 5360 |
| collection | ZDB-35-WIC |
| ctrlnum | (ZDB-35-WIC)ocn264615469 (OCoLC)264615469 (DE-599)BVBBV043388951 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04644nmm a2200925zc 4500</leader><controlfield tag="001">BV043388951</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470292549</subfield><subfield code="9">978-0-470-29254-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470292547</subfield><subfield code="9">0-470-29254-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470292532</subfield><subfield code="9">978-0-470-29253-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470292539</subfield><subfield code="9">0-470-29253-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1281732818</subfield><subfield code="9">1-281-73281-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781281732811</subfield><subfield code="9">978-1-281-73281-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9780470292549</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn264615469</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)264615469</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043388951</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5360</subfield><subfield code="0">(DE-625)147688:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Preclinical safety evaluation of biopharmaceuticals</subfield><subfield code="b">a science-based approach to facilitating clinical trials</subfield><subfield code="c">edited by Joy A. Cavagnaro</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, N.J.</subfield><subfield code="b">Wiley</subfield><subfield code="c">c2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xxvi, 1033 p., [8] p. of plates)</subfield><subfield code="c">25 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"The goal is to provide a comprehensive reference book for the preclinicaldiscovery and development scientist whose responsibilities span target identification, lead candidate selection, pharmacokinetics, pharmacology, and toxicology, and for regulatory scientists whose responsibilities include the evaluation of novel therapies.".-From the Afterword by Anthony D. Dayan. Proper preclinical safety evaluation can improve the predictive value, lessen the time and cost of launching new biopharmaceuticals, and speed potentially lifesaving drugs to market. This guide covers topics ranging</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Online-Ausgabe</subfield><subfield code="n">Mode of access: World Wide Web</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Testing</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical biotechnology / Safety measures</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Products</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / legislation & jurisprudence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Drug Guides</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacy</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Nursing / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological products</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology / Safety measures</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Testing</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biologika</subfield><subfield code="0">(DE-588)7689632-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Klinisches Experiment</subfield><subfield code="0">(DE-588)4164223-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelüberwachung</subfield><subfield code="0">(DE-588)4437717-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Chemie</subfield><subfield code="0">(DE-588)4132158-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bioverfahrenstechnik</subfield><subfield code="0">(DE-588)4307166-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Chemie</subfield><subfield code="0">(DE-588)4132158-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Biologika</subfield><subfield code="0">(DE-588)7689632-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Bioverfahrenstechnik</subfield><subfield code="0">(DE-588)4307166-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="5"><subfield code="a">Arzneimittelüberwachung</subfield><subfield code="0">(DE-588)4437717-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="6"><subfield code="a">Klinisches Experiment</subfield><subfield code="0">(DE-588)4164223-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cavagnaro, Joy A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Reproduktion von</subfield><subfield code="t">Preclinical safety evaluation of biopharmaceuticals</subfield><subfield code="d">c2008</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-470-10884-3</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-470-10884-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9780470292549</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028807535</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9780470292549</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9780470292549</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV043388951 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:24:36Z |
| institution | BVB |
| isbn | 9780470292549 0470292547 9780470292532 0470292539 1281732818 9781281732811 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028807535 |
| oclc_num | 264615469 |
| open_access_boolean | |
| owner | DE-861 |
| owner_facet | DE-861 |
| physical | 1 Online-Ressource (xxvi, 1033 p., [8] p. of plates) 25 cm |
| psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Wiley |
| record_format | marc |
| spelling | Preclinical safety evaluation of biopharmaceuticals a science-based approach to facilitating clinical trials edited by Joy A. Cavagnaro Hoboken, N.J. Wiley c2008 1 Online-Ressource (xxvi, 1033 p., [8] p. of plates) 25 cm txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index "The goal is to provide a comprehensive reference book for the preclinicaldiscovery and development scientist whose responsibilities span target identification, lead candidate selection, pharmacokinetics, pharmacology, and toxicology, and for regulatory scientists whose responsibilities include the evaluation of novel therapies.".-From the Afterword by Anthony D. Dayan. Proper preclinical safety evaluation can improve the predictive value, lessen the time and cost of launching new biopharmaceuticals, and speed potentially lifesaving drugs to market. This guide covers topics ranging Online-Ausgabe Mode of access: World Wide Web Drugs / Testing fast Pharmaceutical biotechnology / Safety measures fast Clinical Trials as Topic / methods Biological Products Clinical Trials as Topic / legislation & jurisprudence Drug Evaluation, Preclinical / methods MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Biological products Clinical Trials as Topic Drug Evaluation, Preclinical Drugs Pharmaceutical biotechnology Medizin Pharmaceutical biotechnology / Safety measures Drugs / Testing Biologika (DE-588)7689632-8 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf Klinisches Experiment (DE-588)4164223-5 gnd rswk-swf Arzneimittelüberwachung (DE-588)4437717-4 gnd rswk-swf Pharmazeutische Chemie (DE-588)4132158-3 gnd rswk-swf Bioverfahrenstechnik (DE-588)4307166-1 gnd rswk-swf Arzneimittelsicherheit (DE-588)4143182-0 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Pharmazeutische Chemie (DE-588)4132158-3 s Biologika (DE-588)7689632-8 s Bioverfahrenstechnik (DE-588)4307166-1 s Arzneimitteldesign (DE-588)4278218-1 s Arzneimittelsicherheit (DE-588)4143182-0 s Arzneimittelüberwachung (DE-588)4437717-4 s Klinisches Experiment (DE-588)4164223-5 s 2\p DE-604 Cavagnaro, Joy A. Sonstige oth Reproduktion von Preclinical safety evaluation of biopharmaceuticals c2008 Erscheint auch als Druck-Ausgabe, Hardcover 0-470-10884-3 Erscheint auch als Druck-Ausgabe, Hardcover 978-0-470-10884-0 https://onlinelibrary.wiley.com/doi/book/10.1002/9780470292549 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Preclinical safety evaluation of biopharmaceuticals a science-based approach to facilitating clinical trials Drugs / Testing fast Pharmaceutical biotechnology / Safety measures fast Clinical Trials as Topic / methods Biological Products Clinical Trials as Topic / legislation & jurisprudence Drug Evaluation, Preclinical / methods MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Biological products Clinical Trials as Topic Drug Evaluation, Preclinical Drugs Pharmaceutical biotechnology Medizin Pharmaceutical biotechnology / Safety measures Drugs / Testing Biologika (DE-588)7689632-8 gnd Arzneimitteldesign (DE-588)4278218-1 gnd Klinisches Experiment (DE-588)4164223-5 gnd Arzneimittelüberwachung (DE-588)4437717-4 gnd Pharmazeutische Chemie (DE-588)4132158-3 gnd Bioverfahrenstechnik (DE-588)4307166-1 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd |
| subject_GND | (DE-588)7689632-8 (DE-588)4278218-1 (DE-588)4164223-5 (DE-588)4437717-4 (DE-588)4132158-3 (DE-588)4307166-1 (DE-588)4143182-0 (DE-588)4143413-4 |
| title | Preclinical safety evaluation of biopharmaceuticals a science-based approach to facilitating clinical trials |
| title_auth | Preclinical safety evaluation of biopharmaceuticals a science-based approach to facilitating clinical trials |
| title_exact_search | Preclinical safety evaluation of biopharmaceuticals a science-based approach to facilitating clinical trials |
| title_full | Preclinical safety evaluation of biopharmaceuticals a science-based approach to facilitating clinical trials edited by Joy A. Cavagnaro |
| title_fullStr | Preclinical safety evaluation of biopharmaceuticals a science-based approach to facilitating clinical trials edited by Joy A. Cavagnaro |
| title_full_unstemmed | Preclinical safety evaluation of biopharmaceuticals a science-based approach to facilitating clinical trials edited by Joy A. Cavagnaro |
| title_short | Preclinical safety evaluation of biopharmaceuticals |
| title_sort | preclinical safety evaluation of biopharmaceuticals a science based approach to facilitating clinical trials |
| title_sub | a science-based approach to facilitating clinical trials |
| topic | Drugs / Testing fast Pharmaceutical biotechnology / Safety measures fast Clinical Trials as Topic / methods Biological Products Clinical Trials as Topic / legislation & jurisprudence Drug Evaluation, Preclinical / methods MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Biological products Clinical Trials as Topic Drug Evaluation, Preclinical Drugs Pharmaceutical biotechnology Medizin Pharmaceutical biotechnology / Safety measures Drugs / Testing Biologika (DE-588)7689632-8 gnd Arzneimitteldesign (DE-588)4278218-1 gnd Klinisches Experiment (DE-588)4164223-5 gnd Arzneimittelüberwachung (DE-588)4437717-4 gnd Pharmazeutische Chemie (DE-588)4132158-3 gnd Bioverfahrenstechnik (DE-588)4307166-1 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd |
| topic_facet | Drugs / Testing Pharmaceutical biotechnology / Safety measures Clinical Trials as Topic / methods Biological Products Clinical Trials as Topic / legislation & jurisprudence Drug Evaluation, Preclinical / methods MEDICAL / Drug Guides MEDICAL / Pharmacology MEDICAL / Pharmacy MEDICAL / Nursing / Pharmacology Biological products Clinical Trials as Topic Drug Evaluation, Preclinical Drugs Pharmaceutical biotechnology Medizin Biologika Arzneimitteldesign Klinisches Experiment Arzneimittelüberwachung Pharmazeutische Chemie Bioverfahrenstechnik Arzneimittelsicherheit Aufsatzsammlung |
| url | https://onlinelibrary.wiley.com/doi/book/10.1002/9780470292549 |
| work_keys_str_mv | AT cavagnarojoya preclinicalsafetyevaluationofbiopharmaceuticalsasciencebasedapproachtofacilitatingclinicaltrials |